To evaluate the expression of different forms of a tumor-specific antibody in plants, we adapted a recently described Agrobacterium-mediated transient expression system. A recombinant single-chain Fv antibody (scFvT84.66) and a full-size mouse͞human chimeric antibody (cT84.66) derived from the parental murine mAb T84.66 specific for the human carcinoembryonic antigen were engineered into a plant expression vector. Chimeric T84.66 heavy and light chain genes were constructed by exchanging the mouse light and heavy chain constant domain sequences with their human counterparts and cloned into two independent plant expression vectors. In vivo assembly of full-size cT84.66 was achieved by simultaneous expression of the light and heavy chains after vacuum infiltration of tobacco leaves with two populations of recombinant Agrobacterium. Upscaling the transient system permitted purification of functional recombinant antibodies from tobacco leaf extracts within a week. His6-tagged scFvT84.66 was purified by immobilized metal affinity chromatography and cT84.66 by protein A affinity chromatography. Sufficient amounts of recombinant antibodies were recovered for detailed characterization by SDS͞PAGE, Western blotting, and ELISA.Monoclonal antibodies are essential tools in biology, biochemistry, and medicine. Their high affinity and specificity make them invaluable for diagnostic and therapeutic applications. However, the therapeutic use of murine mAbs is limited because they elicit a human anti-mouse antibody response and large amounts of antibody are required for therapy. These limitations may be overcome by engineering humanized antibodies and by producing these proteins in plants.The human anti-mouse antibody response can be reduced by using recombinant antibody (rAb) technology to replace the murine light and heavy chain constant domains with the corresponding human domains and the remaining murine variable domains to maintain the antigen specificity and affinity of the original mAb. A second approach is to use single-chain Fv antibody fragments (scFvs) where the constant domains have been removed and the variable domains are joined by a flexible linker (1). Compared with the full-size antibodies, scFvs display better tumor penetration and faster serum clearance but exhibit no effector functions. A critical step in testing the potential therapeutic use of these molecules is the development of a reproducible and efficient method for large-scale antibody production.Plants are potentially the most economical system for largescale production of rAbs (2, 3). rAbs are efficiently folded and assembled within the endoplasmic reticulum (ER) of plant cells (4-6) and retain the antigen binding properties of the antibodies produced by plasma or hybridoma cells (2,5,(7)(8)(9). Since the first report of antibody expression in transgenic plants (7), different engineered antibodies have been produced successfully, including full-size antibodies (8-11), Fab fragments (12), scFvs (13-21), and single-domain antibodies (22).Regene...